136 related articles for article (PubMed ID: 9371233)
21. Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid.
Marastoni M; Fantin G; Bortolotti F; Tomatis R
Arzneimittelforschung; 1996 Nov; 46(11):1099-101. PubMed ID: 8955873
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of prodrug-type anti-HIV agents: ester conjugates of carboxylic acid-containing dipeptide HIV protease inhibitors and a reverse transcriptase inhibitor.
Matsumoto H; Matsuda T; Nakata S; Mitoguchi T; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2001 Feb; 9(2):417-30. PubMed ID: 11249134
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of novel 4-hydroxypyrone derivatives as HIV-1 protease inhibitors.
Sun CL; Pang RF; Zhang H; Yang M
Bioorg Med Chem Lett; 2005 Jul; 15(13):3257-62. PubMed ID: 15923115
[TBL] [Abstract][Full Text] [Related]
24. Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.
Skulnick HI; Johnson PD; Aristoff PA; Morris JK; Lovasz KD; Howe WJ; Watenpaugh KD; Janakiraman MN; Anderson DJ; Reischer RJ; Schwartz TM; Banitt LS; Tomich PK; Lynn JC; Horng MM; Chong KT; Hinshaw RR; Dolak LA; Seest EP; Schwende FJ; Rush BD; Howard GM; Toth LN; Wilkinson KR; Romines KR
J Med Chem; 1997 Mar; 40(7):1149-64. PubMed ID: 9089336
[TBL] [Abstract][Full Text] [Related]
25. Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.
Jadhav PK; Woerner FJ; Lam PY; Hodge CN; Eyermann CJ; Man HW; Daneker WF; Bacheler LT; Rayner MM; Meek JL; Erickson-Viitanen S; Jackson DA; Calabrese JC; Schadt M; Chang CH
J Med Chem; 1998 Apr; 41(9):1446-55. PubMed ID: 9554878
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity.
Wei Y; Ma CM; Hattori M
Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591
[TBL] [Abstract][Full Text] [Related]
27. Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.
Miller JF; Brieger M; Furfine ES; Hazen RJ; Kaldor I; Reynolds D; Sherrill RG; Spaltenstein A
Bioorg Med Chem Lett; 2005 Aug; 15(15):3496-500. PubMed ID: 15990305
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of novel conformationally restricted HIV protease inhibitors.
Salituro FG; Baker CT; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Porter MD; Schairer WC; Tung RD
Bioorg Med Chem Lett; 1998 Dec; 8(24):3637-42. PubMed ID: 9934485
[TBL] [Abstract][Full Text] [Related]
29. Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.
Jadhav PK; Ala P; Woerner FJ; Chang CH; Garber SS; Anton ED; Bacheler LT
J Med Chem; 1997 Jan; 40(2):181-91. PubMed ID: 9003516
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors.
Marastoni M; Bazzaro M; Bortolotti F; Tomatis R
Arzneimittelforschung; 2000 Jun; 50(6):564-8. PubMed ID: 10918952
[TBL] [Abstract][Full Text] [Related]
31. A new anti-HIV triterpene from Geum japonicum.
Xu HX; Ming DS; Dong H; But PP
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1367-9. PubMed ID: 10993241
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors.
Peçanha EP; Figueiredo LJ; Brindeiro RM; Tanuri A; Calazans AR; Antunes OA
Farmaco; 2003 Feb; 58(2):149-57. PubMed ID: 12581781
[TBL] [Abstract][Full Text] [Related]
33. Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.
Thaisrivongs S; Watenpaugh KD; Howe WJ; Tomich PK; Dolak LA; Chong KT; Tomich CC; Tomasselli AG; Turner SR; Strohbach JW
J Med Chem; 1995 Sep; 38(18):3624-37. PubMed ID: 7658450
[TBL] [Abstract][Full Text] [Related]
34. Cyclic HIV-1 protease inhibitors derived from mannitol: synthesis, inhibitory potencies, and computational predictions of binding affinities.
Hultén J; Bonham NM; Nillroth U; Hansson T; Zuccarello G; Bouzide A; Aqvist J; Classon B; Danielson UH; Karlén A; Kvarnström I; Samuelsson B; Hallberg A
J Med Chem; 1997 Mar; 40(6):885-97. PubMed ID: 9083477
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors.
Randolph JT; Huang PP; Flosi WJ; DeGoey D; Klein LL; Yeung CM; Flentge C; Sun M; Zhao C; Dekhtyar T; Mo H; Colletti L; Kati W; Marsh KC; Molla A; Kempf DJ
Bioorg Med Chem; 2006 Jun; 14(12):4035-46. PubMed ID: 16504523
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and human immunodeficiency virus (HIV)-1 protease inhibitory activity of tripeptide analogues containing a dioxoethylene moiety.
Kitazaki T; Asano T; Kato K; Kishimoto S; Itoh K
Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2636-40. PubMed ID: 7697778
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus.
Lu Z; Raghavan S; Bohn J; Charest M; Stahlhut MW; Rutkowski CA; Simcoe AL; Olsen DB; Schleif WA; Carella A; Gabryelski L; Jin L; Lin JH; Emini E; Chapman K; Tata JR
Bioorg Med Chem Lett; 2003 May; 13(10):1821-4. PubMed ID: 12729673
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors.
Baker CT; Salituro FG; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Schairer WC; Tung RD
Bioorg Med Chem Lett; 1998 Dec; 8(24):3631-6. PubMed ID: 9934484
[TBL] [Abstract][Full Text] [Related]
39. Profile of CGP 61755: a novel and potent HIV-1 protease inhibitor that shows enhanced anti-HIV activity when combined with other antiretroviral agents in vitro.
Lazdins JK; Bold G; Capraro HG; Cozens R; Fässler A; Flesch G; Klimkait T; Lang M; Mestan J; Poncioni B; Rösel J; Stover D; Tintelnot-Blomley M; Walker MR; Woods-Cook K
Schweiz Med Wochenschr; 1996 Oct; 126(43):1849-51. PubMed ID: 8916294
[TBL] [Abstract][Full Text] [Related]
40. Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds.
Spaltenstein A; Almond MR; Bock WJ; Cleary DG; Furfine ES; Hazen RJ; Kazmierski WM; Salituro FG; Tung RD; Wright LL
Bioorg Med Chem Lett; 2000 Jun; 10(11):1159-62. PubMed ID: 10866371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
